Immatics (IMTX) Profit After Tax (2019 - 2025)
Immatics recorded quarterly Profit After Tax of -$41.6 million in Q4 2025, up 29.68% quarter-over-quarter from -$59.1 million in Q3 2025, and down 204.69% year-over-year from $39.7 million in Q4 2024.
Immatics' Profit After Tax history runs 7 years deep, the most recent figure standing at -$41.6 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 204.69% year-over-year to -$41.6 million; the TTM figure through Dec 2025 stood at -$64.0 million (down 224.55% YoY), while the FY2025 annual figure was -$221.9 million, down 1464.84% from the prior year.
- Profit After Tax came in at -$41.6 million for Q4 2025 at Immatics, up from -$59.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $96.1 million in Q1 2022 to a low of -$59.1 million in Q3 2025.
- A 5-year average of $1.1 million and a median of -$12.5 million in 2021 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 449.38% in 2022 and sank 2196.9% in 2025, its largest moves.
- Immatics' Profit After Tax stood at -$19.2 million in 2021, then fell by 22.42% to -$23.5 million in 2022, then retreated by 8.94% to -$25.6 million in 2023, then surged by 254.98% to $39.7 million in 2024, then sank by 204.69% to -$41.6 million in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$41.6 million, -$59.1 million, and $79.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | -41.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.55 Mn |
| Sep 30, 2025 | -59.09 Mn |
| Jun 30, 2025 | 79.63 Mn |
| Mar 31, 2025 | -42.97 Mn |
| Dec 31, 2024 | 39.69 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | 19.38 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | 26.80 Mn |
| Mar 31, 2023 | -21.20 Mn |
| Dec 31, 2022 | -23.51 Mn |
| Sep 30, 2022 | -21.11 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 96.14 Mn |
| Dec 31, 2021 | -19.20 Mn |
| Sep 30, 2021 | 32.08 Mn |
| Jun 30, 2021 | 31.95 Mn |
| Mar 31, 2021 | -27.52 Mn |
| Dec 31, 2020 | -21.43 Mn |
| Sep 30, 2020 | -191.51 Mn |
| Jun 30, 2020 | 23.49 Mn |
| Mar 31, 2020 | -9.47 Mn |
| Dec 31, 2019 | -16.53 Mn |
| Sep 30, 2019 | -5.53 Mn |
| Jun 30, 2019 | -7.52 Mn |